Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elzbieta Nowara

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Plos One|March 14, 2012
PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neckMiroslaw Snietura, Magdalena Jaworska, Joanna Mlynarczyk-Liszka, et al.
Cancer Chemotherapy and Pharmacology|August 12, 2009
Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanesAlison Jones, Mary O'Brien, Harald Sommer, et al.
Ginekologia Polska|March 6, 2012
[Usefulness of osteopontin (OPN) determinations in ovarian cancer patients who underwent first-line chemotherapy]Jolanta Mrochem-Kwarciak, Izolda Mrochen-Domin, Andrzej Wojcieszek, et al.
Blood|April 17, 2010
Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemiaSebastian Giebel, Myriam Labopin, Gerhard Ehninger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2014
Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancerEric Van Cutsem, Cathy Eng, Elzbieta Nowara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancerR Wendel Naumann, Robert L Coleman, Robert A Burger, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Plos One|March 14, 2012
PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neckMiroslaw Snietura, Magdalena Jaworska, Joanna Mlynarczyk-Liszka, et al.
Cancer Chemotherapy and Pharmacology|August 12, 2009
Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanesAlison Jones, Mary O'Brien, Harald Sommer, et al.
Ginekologia Polska|March 6, 2012
[Usefulness of osteopontin (OPN) determinations in ovarian cancer patients who underwent first-line chemotherapy]Jolanta Mrochem-Kwarciak, Izolda Mrochen-Domin, Andrzej Wojcieszek, et al.
Blood|April 17, 2010
Association of Human Development Index with rates and outcomes of hematopoietic stem cell transplantation for patients with acute leukemiaSebastian Giebel, Myriam Labopin, Gerhard Ehninger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2014
Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancerEric Van Cutsem, Cathy Eng, Elzbieta Nowara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2013
PRECEDENT: a randomized phase II trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD) in combination versus PLD alone in patients with platinum-resistant ovarian cancerR Wendel Naumann, Robert L Coleman, Robert A Burger, et al.
Pageof 2